COMMUNIQUÉS West-GlobeNewswire

PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"
16/12/2025
Revolutionary Veterinary AI Platform Ditches Dense Documentation in Favor of Clear, Engaging Video Walkthrough MINNEAPOLIS, MN, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo.ai, the AI powered platform transforming how [...]
Valerie Health Raises $30M Series A to Bring AI Front Office to Independent Provider Groups
16/12/2025
Redpoint Ventures leads the round as Valerie’s embedded AI and human teams cut administrative costs, speed scheduling, and turn lost referrals into patient visits SAN FRANCISCO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Valerie [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 15, 2025 it granted stock options to purchase an aggregate of 21,399 shares of [...]
Cellution Biologics Inc. Announces First Peer-Reviewed Publication Demonstrating Positive Outcomes for AmchoPlast™ in the Treatment of Chronic Diabetic Foot Ulcers
16/12/2025
ROSWELL, Ga., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cellution Biologics, Inc., a leader in regenerative allograft solutions, proudly announces the publication of its first peer-reviewed clinical article, “Bridging the Wound [...]
Simple Consult Expands Access to $29 Online Healthcare Across 19 States
16/12/2025
The independently owned telehealth platform offers same-day visits, prescription refills, and everyday care with transparent pricing and no insurance required Dover, Delaware, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Simple [...]
Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer
16/12/2025
LOS ANGELES, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the [...]
Information marché
16/12/2025
Communiqué de presse Paris - Le 16 décembre 2025 - EUROAPI annonce, ce jour, que ses principaux actionnaires, Sanofi et EPIC Bpifrance, ont donné leur accord pour étendre la période de conservation de leurs actions [...]
Market update
16/12/2025
Press Release Paris – December 16, 2025 - EUROAPI announced today that its main shareholders, Sanofi and EPIC Bpifrance, have agreed to extend further the duration of their lock-up until December 18, 2026, subject to [...]
Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance
16/12/2025
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA [...]
Pathway Health’s Lisa Thomson Receives 2026 McKnight’s Pinnacle Award
16/12/2025
LAKE ELMO, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Pathway Health , a leading provider of health care consulting services, interim and permanent talent, technology implementation, and training, is pleased to announce [...]
Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel
16/12/2025
Newborn screening is the only practical means of diagnosing MLD prior to the onset of symptoms, which is key to achieving optimal outcomes for children and their families with this rapidly progressive disease As of [...]
Tiny Health and Bristle Health Launch Groundbreaking Study on Oral-Gut Health Connection
16/12/2025
First-of-its-kind research offers participants exclusive access to combined oral and gut microbiome testing AUSTIN, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Tiny Health and Bristle Health are recruiting participants for [...]
Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
16/12/2025
TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the University Health Network Research Ethics Board (“UHN REB”) has [...]
Marine Biologics Named a Top Food Technology Company for 2025 in Global Food Tech Awards
16/12/2025
Innovator building the AI for clean-label ingredient discovery is recognized as a global game-changing technology shaping the future of food BERKELEY, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Marine Biologics today [...]
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America
16/12/2025
Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco Mexico WESTBROOK, Maine, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company [...]
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
16/12/2025
The registrational TACTI-004 Phase III has enrolled 289 patients globally, over 38% of the trial’s targeted enrolment Strong operational progress continues globally with over 120 activated clinical sites and 27 [...]
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
16/12/2025
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that it is [...]
Elicio Therapeutics Reports Inducement Grants
16/12/2025
BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
Annovis to Host Corporate Update Webinar on January 28, 2026
16/12/2025
MALVERN, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]

Pages